Investigative therapy for melanoma promising

Combination of chemotherapy and immunotherapy of adoptive cell transfer with tumor infiltrating lymphocytes, followed by interleukin-2, is labor-intensive but a feasible therapy with a high response rate in treated patients.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *